The role of molds in the relation between indoor environment and atopy in asthma patients

Emel Ceylan1, Sibel Doruk2, Sebahat Genc3

  • 1Department of Pulmonary Medicine, Adnan Menderes University, Aydın, Turkey.

Abstract

Insights

Mold exposure in homes may influence allergic sensitization, particularly in individuals with asthma. Identifying mold as a common allergen suggests strategies to reduce exposure could improve asthma management.

Area of Science:

  • Environmental Science
  • Allergy and Immunology
  • Pulmonology

Background:

  • The impact of mold fungi on allergic sensitization remains unclear.
  • This study investigated the link between indoor mold exposure and atopy in asthmatic patients.

Purpose of the Study:

  • To evaluate the role of indoor mold exposure in the development of atopy among asthmatics.
  • To assess the relationship between environmental factors and allergic sensitization in asthma.

Main Methods:

  • Air samples from homes of asthmatics and controls were cultured for mold.
  • Allergy skin testing was conducted on participants.
  • Environmental parameters like temperature and humidity were measured.

Main Results:

  • Atopy incidence was comparable between asthmatics (59.1%) and controls (51.4%).
  • Mold levels averaged 35.9 CFU/m³ in asthmatics' homes and 34.3 CFU/m³ in controls'.
  • Higher household occupancy correlated with increased mold presence; childhood village living was more common in atopics.

Conclusions:

  • Childhood living environment may influence atopy and asthma development.
  • Molds were the second most frequent allergen identified, after mites.
  • Assessing mold sensitization and educating patients on avoidance may aid uncontrolled asthma management.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
49